Your browser doesn't support javascript.
loading
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.
Maréchal, Raphaël; Bachet, Jean-Baptiste; Mackey, John R; Dalban, Cécile; Demetter, Pieter; Graham, Kathryn; Couvelard, Anne; Svrcek, Magali; Bardier-Dupas, Armelle; Hammel, Pascal; Sauvanet, Alain; Louvet, Christophe; Paye, François; Rougier, Philippe; Penna, Christophe; André, Thierry; Dumontet, Charles; Cass, Carol E; Jordheim, Lars Petter; Matera, Eva-Laure; Closset, Jean; Salmon, Isabelle; Devière, Jacques; Emile, Jean-François; Van Laethem, Jean-Luc.
Afiliação
  • Maréchal R; Department of Gastroenterology and Gastrointestinal Cancer Unit, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: raphael.marechal@erasme.ulb.ac.be.
  • Bachet JB; Medical University Pierre et Marie Curie, UFR Paris VI, Paris, France; EA4340 "Epidémiologie et oncogènes des tumeurs digestives," Versailles Saint-Quentin-en-Yvelines University, Saint-Quentin-en-Yvelines, France; Department of Hepato-Gastroenterology, Pitié Salpêtrière Hospital, APHP, Paris, Franc
  • Mackey JR; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Dalban C; Department of Biostatistics and Epidemiology (EA4184), Georges François Leclerc Center, Dijon, France.
  • Demetter P; Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, and DIAPATH, Brussels, Belgium.
  • Graham K; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Couvelard A; Department of Pathology, Beaujon Hospital, APHP, Clichy, France.
  • Svrcek M; Department of Pathology, Saint Antoine Hospital, APHP, Paris, France.
  • Bardier-Dupas A; Medical University Pierre et Marie Curie, UFR Paris VI, Paris, France; Department of Pathology, Pitié Salpêtrière Hospital, APHP, Paris, France.
  • Hammel P; Department of Gastroenterology, Beaujon Hospital, APHP, Clichy, France.
  • Sauvanet A; Department of Surgery, Beaujon Hospital, APHP, Clichy, France.
  • Louvet C; Medical University Pierre et Marie Curie, UFR Paris VI, Paris, France; Department of Oncology, Saint Antoine Hospital, APHP, Paris, France.
  • Paye F; Medical University Pierre et Marie Curie, UFR Paris VI, Paris, France; Department of Surgery, Saint Antoine Hospital, APHP, Paris, France.
  • Rougier P; EA4340 "Epidémiologie et oncogènes des tumeurs digestives," Versailles Saint-Quentin-en-Yvelines University, Saint-Quentin-en-Yvelines, France; Department of Digestive Oncology, Hôpital Européen Georges Pompidou, APHP, Paris, France.
  • Penna C; EA4340 "Epidémiologie et oncogènes des tumeurs digestives," Versailles Saint-Quentin-en-Yvelines University, Saint-Quentin-en-Yvelines, France; Department of Surgery, Ambroise Paré Hospital, APHP, Boulogne Billancourt, France.
  • André T; Medical University Pierre et Marie Curie, UFR Paris VI, Paris, France; Department of Hepato-Gastroenterology, Pitié Salpêtrière Hospital, APHP, Paris, France.
  • Dumontet C; Centre de Cancer de Lyon, Lyon, France; Hospices Civils de Lyon, Lyon, France.
  • Cass CE; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Jordheim LP; Centre de Cancer de Lyon, Lyon, France.
  • Matera EL; Centre de Cancer de Lyon, Lyon, France.
  • Closset J; Department of Surgery, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Salmon I; Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, and DIAPATH, Brussels, Belgium.
  • Devière J; Department of Gastroenterology and Gastrointestinal Cancer Unit, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Emile JF; EA4340 "Epidémiologie et oncogènes des tumeurs digestives," Versailles Saint-Quentin-en-Yvelines University, Saint-Quentin-en-Yvelines, France; Department of Pathology, Ambroise Paré Hospital, APHP, Boulogne Billancourt, France.
  • Van Laethem JL; Department of Gastroenterology and Gastrointestinal Cancer Unit, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Gastroenterology ; 143(3): 664-674.e6, 2012 Sep.
Article em En | MEDLINE | ID: mdl-22705007
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Proteínas Supressoras de Tumor / Transportador Equilibrativo 1 de Nucleosídeo / Desoxicitidina / Desoxicitidina Quinase / Antimetabólitos Antineoplásicos País/Região como assunto: Europa Idioma: En Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Proteínas Supressoras de Tumor / Transportador Equilibrativo 1 de Nucleosídeo / Desoxicitidina / Desoxicitidina Quinase / Antimetabólitos Antineoplásicos País/Região como assunto: Europa Idioma: En Ano de publicação: 2012 Tipo de documento: Article